| dc.contributor | Consorci Sanitari de Terrassa |
| dc.contributor.author | Puigdellívol-Sánchez, Anna |
| dc.contributor.author | Juanes, Marta |
| dc.contributor.author | Calderon Valdiviezo, Ana Isabel |
| dc.contributor.author | Losa, Helena |
| dc.contributor.author | González Salvador, Marta |
| dc.contributor.author | Leon, Marc |
| dc.contributor.author | Pueyo Anton, Luis |
| dc.contributor.author | Franco-Romero, M |
| dc.contributor.author | Lozano-Paz, Celia |
| dc.contributor.author | Cortés Borra, Albert |
| dc.contributor.author | Valls, Roger |
| dc.date.accessioned | 2025-09-03T11:15:29Z |
| dc.date.available | 2025-09-03T11:15:29Z |
| dc.date.issued | 2025-05-27 |
| dc.identifier.citation | Puigdellívol-Sánchez A, Juanes-González M, Calderón-Valdiviezo AI, Losa-Puig H, González-Salvador M, León-Pérez M, et al. COVID-19 Pandemic Waves and 2024-2025 Winter Season in Relation to Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and Amantadine. Healthcare (Basel). 2025 May 27;13(11):1270. |
| dc.identifier.issn | 2227-9032 |
| dc.identifier.uri | http://hdl.handle.net/11351/13598 |
| dc.description | ACE inhibitors; COVID-19; Amantadine |
| dc.language.iso | eng |
| dc.publisher | MDPI |
| dc.relation.ispartofseries | Healthcare (Basel, Switzerland);13(11) |
| dc.rights | Attribution-NonCommercial 4.0 International |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Enzim conversiu de l'angiotensina - Inhibidors |
| dc.subject | Angiotensines |
| dc.subject | COVID-19 (Malaltia) - Mortalitat |
| dc.subject.mesh | Angiotensin-Converting Enzyme Inhibitors |
| dc.subject.mesh | Angiotensin Receptor Antagonists |
| dc.subject.mesh | Coronavirus Infections |
| dc.title | COVID-19 Pandemic Waves and 2024-2025 Winter Season in Relation to Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and Amantadine |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.3390/healthcare13111270 |
| dc.subject.decs | inhibidores de la enzima convertidora de angiotensina |
| dc.subject.decs | antagonistas de receptores de angiotensina |
| dc.subject.decs | infecciones por Coronavirus |
| dc.relation.publishversion | https://www.doi.org/10.3390/healthcare13111270 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.authoraffiliation | [Puigdellívol-Sánchez A] Medicina de Família, Centre d’Atenció Primària (CAP) Anton de Borja-Centre Universitari, Consorci Sanitari de Terrassa (CST), Rubí, Spain. Unitat d’Anatomia i Embriologia Humana, Departament de Patologia i Terapèutica Experimental, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain. [Juanes-Gonzáles M, Calderón-Valdiviezo, Lozano-Paz C, Valls-Foix R, León-Pérez M] Medicina de Família, Centre d’Atenció Primària (CAP) Anton de Borja-Centre Universitari, Consorci Sanitari de Terrassa (CST), Rubí, Spain. [Losa-Puig H] Medicina de Família, Centre d’Atenció Primària (CAP) Anton de Borja-Centre Universitari, Consorci Sanitari de Terrassa (CST), Rubí, Spain. Hospital Álvaro Cunqueiro, Vigo, Spain. [González-Salvador M] Unitat de Control de gestió i Anàlisi de la Informació, Hospital de Terrassa, Consorci Sanitari de Terrassa (CST), Terrassa, Spain. [Franco-Romero M] Medicina de Família, Centre d’Atenció Primària (CAP) Anton de Borja-Centre Universitari, Consorci Sanitari de Terrassa (CST), Rubí, Spain. Parc Sanitari Pere Virgili, Barcelona, Spain. [Cortés-Borra A] Centre d’Atenció Primària (CAP) La Garriga, Institut Català de la Salut, La Garriga, Spain |
| dc.identifier.pmid | 40508884 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |